197 related articles for article (PubMed ID: 32563247)
21. EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
Schernthaner G; Schernthaner-Reiter MH; Schernthaner GH
Clin Ther; 2016 Jun; 38(6):1288-1298. PubMed ID: 27210264
[TBL] [Abstract][Full Text] [Related]
22. A retrospective cohort study on the risk of stroke in relation to a priori health knowledge level among people with type 2 diabetes mellitus in Taiwan.
Lai YJ; Hu HY; Lee YL; Ku PW; Yen YF; Chu D
BMC Cardiovasc Disord; 2017 May; 17(1):130. PubMed ID: 28532430
[TBL] [Abstract][Full Text] [Related]
23. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
[TBL] [Abstract][Full Text] [Related]
24. Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study.
Liu CY; Chen HC
Cardiol J; 2019; 26(6):704-710. PubMed ID: 29718533
[TBL] [Abstract][Full Text] [Related]
25. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
26. Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.
Hsiao FY; Huang WF; Wen YW; Chen PF; Kuo KN; Tsai YW
Drug Saf; 2009; 32(8):675-90. PubMed ID: 19591532
[TBL] [Abstract][Full Text] [Related]
27. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
Inzucchi SE; Viscoli CM; Young LH; Furie KL; Gorman M; Lovejoy AM; Dagogo-Jack S; Ismail-Beigi F; Korytkowski MT; Pratley RE; Schwartz GG; Kernan WN;
Diabetes Care; 2016 Oct; 39(10):1684-92. PubMed ID: 27465265
[TBL] [Abstract][Full Text] [Related]
28. Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study).
Krishnappa M; Patil K; Parmar K; Trivedi P; Mody N; Shah C; Faldu K; Maroo S; ; Parmar D
Cardiovasc Diabetol; 2020 Jun; 19(1):93. PubMed ID: 32560724
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone Therapy in Patients With Stroke and Prediabetes: A Post Hoc Analysis of the IRIS Randomized Clinical Trial.
Spence JD; Viscoli CM; Inzucchi SE; Dearborn-Tomazos J; Ford GA; Gorman M; Furie KL; Lovejoy AM; Young LH; Kernan WN;
JAMA Neurol; 2019 May; 76(5):526-535. PubMed ID: 30734043
[TBL] [Abstract][Full Text] [Related]
30. Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" study.
Mohammedi K; Fauchier L; Quignot N; Khachatryan A; Banon T; Kapnang R; Kikuchi K; Ren H; Massien C; Vigié L; Larsen S; Sibon I
Cardiovasc Diabetol; 2024 May; 23(1):183. PubMed ID: 38812009
[TBL] [Abstract][Full Text] [Related]
31. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
Jil M; Rajnikant M; Richard D; Iskandar I
Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
[TBL] [Abstract][Full Text] [Related]
32. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.
Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes: A case-control study in Taiwan.
Lai SW; Lin HF; Lin CL; Liao KF
Medicine (Baltimore); 2016 Aug; 95(31):e4455. PubMed ID: 27495077
[TBL] [Abstract][Full Text] [Related]
34. Impact of treatment with pioglitazone on stroke outcomes: A real-world database analysis.
Morgan CL; Inzucchi SE; Puelles J; Jenkins-Jones S; Currie CJ
Diabetes Obes Metab; 2018 Sep; 20(9):2140-2147. PubMed ID: 29732718
[TBL] [Abstract][Full Text] [Related]
35. Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke.
Li YR; Tsai SS; Chen DY; Chen ST; Sun JH; Chang HY; Liou MJ; Chen TH
Cardiovasc Diabetol; 2018 Jan; 17(1):2. PubMed ID: 29301579
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES).
Armato JP; DeFronzo RA; Abdul-Ghani M; Ruby RJ
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):781-789. PubMed ID: 30224284
[TBL] [Abstract][Full Text] [Related]
37. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Patorno E; Gopalakrishnan C; Brodovicz KG; Meyers A; Bartels DB; Liu J; Kulldorff M; Schneeweiss S
Diabetes Obes Metab; 2019 Aug; 21(8):1824-1836. PubMed ID: 30941884
[TBL] [Abstract][Full Text] [Related]
39. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.
Nesti L; Tricò D; Mengozzi A; Natali A
Cardiovasc Diabetol; 2021 May; 20(1):109. PubMed ID: 34006325
[TBL] [Abstract][Full Text] [Related]
40. Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study.
Chen TH; Li YR; Chen SW; Lin YS; Sun CC; Chen DY; Mao CT; Wu M; Chang CH; Chu PH; Wu VC
Cardiovasc Diabetol; 2020 Nov; 19(1):189. PubMed ID: 33167990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
